Jiangsu Nhwa Pharmaceutical Co., Ltd.
002262
Clasificación en acciones
#4591
Jiangsu Nhwa Pharmaceutical Co., LTD operates as a global pharmaceutical... Jiangsu Nhwa Pharmaceutical Co., LTD operates as a global pharmaceutical entity, focusing on the research, production, and sale of treatments for the central nervous system, along with cardiovascular and cerebrovascular ailments. Its comprehensive product line includes therapeutics for anesthesia, psychiatry, and neurological disorders. Additionally, the company is a supplier of Active Pharmaceutical Ingredients (APIs), specifically for central nervous system, anesthetic, and sedative applications, among others. The firm was established in 1978 and is based in Xuzhou, China.
Precio por acción
$3.26
Capitalización bursátil
$3.30B
Cambio (1 día)
-0.55%
Cambio (1 año)
-9.98%
País
CN
Comercio Jiangsu Nhwa Pharmaceutical Co., Ltd. (002262)
Categoría
Healthcare
Ingresos de Jiangsu Nhwa Pharmaceutical Co., Ltd. (002262)
Ingresos en Jun 2026 TTM: $886.77M
Según los últimos informes financieros de Jiangsu Nhwa Pharmaceutical Co., Ltd., los ingresos actuales de la empresa (TTM) son $886.77M. En 2023, la empresa obtuvo unos ingresos de $712.22M un aumento con respecto a los ingresos del año 2022, que fueron de $623.16M. Los ingresos representan la cantidad total que una empresa genera por la venta de bienes o servicios. A diferencia de las ganancias, no se restan los gastos.
Historial de ingresos de Jiangsu Nhwa Pharmaceutical Co., Ltd. desde 2005 hasta 2026
Ingresos al final de cada año
| Año | Ingresos | Cambiar |
|---|---|---|
| 2026 (TTM) | $886.77M | 13.60% |
| 2024 | $780.59M | 9.60% |
| 2023 | $712.22M | 14.29% |
| 2022 | $623.16M | 0.64% |
| 2021 | $619.21M | 20.34% |
| 2020 | $514.54M | -13.65% |
| 2019 | $595.88M | 6.24% |
| 2018 | $560.89M | 7.53% |
| 2017 | $521.61M | 20.00% |
| 2016 | $434.66M | 2.02% |
| 2015 | $426.03M | 5.50% |
| 2014 | $403.84M | 9.55% |
| 2013 | $368.64M | 15.95% |
| 2012 | $317.92M | 26.25% |
| 2011 | $251.82M | 27.80% |
| 2010 | $197.05M | 21.09% |
| 2009 | $162.72M | 16.57% |
| 2008 | $139.59M | 26.64% |
| 2007 | $110.22M | 23.66% |
| 2006 | $89.14M | 12.63% |
| 2005 | $79.14M | 0.00% |
Ingresos de empresas similares o competidoras
| Empresa | Ingresos | Diferencia de ingresos | País |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $6.61B | 645.58% |
IN
|
